Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells

被引:0
|
作者
Toshiki Nakaoka
Akinobu Ota
Takayuki Ono
Sivasundaram Karnan
Hiroyuki Konishi
Akifumi Furuhashi
Yukinobu Ohmura
Yoichi Yamada
Yoshitaka Hosokawa
Yoshiaki Kazaoka
机构
[1] Aichi Medical University Hospital,Department of Oral and Maxillofacial Surgery
[2] Aichi Medical University School of Medicine,Department of Biochemistry
来源
Cellular Oncology | 2014年 / 37卷
关键词
Arsenic trioxide; Cisplatin; Oral squamous cell carcinoma; Apoptosis; Reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:119 / 129
页数:10
相关论文
共 50 条
  • [31] Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells
    Sturlan, S
    Baumgartner, M
    Roth, E
    Bachleitner-Hofmann, T
    BLOOD, 2003, 101 (12) : 4990 - 4997
  • [32] Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo
    Zhang, Xinyan
    Su, Ying
    Zhang, Min
    CANCER RESEARCH, 2012, 72
  • [33] Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
    Ally, Mina S.
    Ransohoff, Katherine
    Sarin, Kavita
    Atwood, Scott X.
    Rezaee, Melika
    Bailey-Healy, Irene
    Kim, Jynho
    Beachy, Philip A.
    Chang, Anne Lynn S.
    Oro, Anthony
    Tang, Jean Y.
    Colevas, A. Dimitrios
    JAMA DERMATOLOGY, 2016, 152 (04) : 452 - 456
  • [34] Silence of Beclin1 in oral squamous cell carcinoma cells promotes proliferation, inhibits apoptosis, and enhances chemosensitivity
    Wang, Xia
    Li, Shu
    Wu, Shuhua
    Xie, Lulu
    Wang, Peiyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8424 - 8433
  • [35] The Differential Metabolic Response of Oral Squamous Cell Carcinoma Cells and Normal Oral Epithelial Cells to Cisplatin Exposure
    Chen, Xun
    Kuang, Sufang
    He, Yi
    Li, Hongyu
    Yi, Chen
    Li, Yiming
    Wang, Chao
    Chen, Guanhui
    Chen, Shangwu
    Yu, Dongsheng
    METABOLITES, 2022, 12 (05)
  • [36] Nutlin-3 suppresses tumorigenesis and progression of oral squamous cell carcinoma and enhances chemosensitivity to cisplatin
    Kai Zheng
    Zexi Li
    Xu Ding
    Huaiqi Li
    Cytotechnology, 2023, 75 : 17 - 25
  • [37] Nutlin-3 suppresses tumorigenesis and progression of oral squamous cell carcinoma and enhances chemosensitivity to cisplatin
    Zheng, Kai
    Li, Zexi
    Ding, Xu
    Li, Huaiqi
    CYTOTECHNOLOGY, 2023, 75 (01) : 17 - 25
  • [38] ANTITUMOR ACTIVITY OF SATRAPLATIN IN CISPLATIN-RESISTANT ORAL SQUAMOUS CELL CARCINOMA CELLS
    Yamano, Yukio
    Shiiba, Masashi
    Negoro, Kenji
    Nakatani, Ken
    Kasamatsu, Atsushi
    Yamatoji, Masanobu
    Sakuma, Kentaro
    Ogoshi, Kenji
    Iyoda, Manabu
    Shinozuka, Keiji
    Yokoe, Hidetaka
    Wada, Takeshi
    Fujita, Shigeyuki
    Iwasawa, Shunichiro
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Uzawa, Katsuhiro
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (03): : 309 - 317
  • [39] Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma Cells
    Lin, Cheng-Wen
    Bai, Li-Yuan
    Su, Jui-Hsin
    Chiu, Chang-Fang
    Lin, Wei-Yu
    Huang, Wei-Ting
    Shih, Ming-Cheng
    Huang, Yu-Ting
    Hu, Jing-Lan
    Weng, Jing-Ru
    BIOMEDICINES, 2020, 8 (09)
  • [40] Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines
    Shen, Jun
    Huang, Canhua
    Jiang, Lu
    Gao, Feng
    Wang, Zhi
    Zhang, Yuanyuan
    Bai, Jingping
    Zhou, Hongmei
    Chen, Qianming
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (12) : 1901 - 1909